期刊文献+

信号转导和转录激活因子3信号通路在多亮氨酸重复区免疫球蛋白样蛋白1诱导U251细胞凋亡中的作用 被引量:4

Roles of signal transducers and activators of transcription 3 signaling pathway in leucine-rich re- peats and immunoglobulin-like domains 1-induced apoptosis of U251 cells
原文传递
导出
摘要 目的探讨信号转导和转录激活因子3 (STAT3)信号通路在多亮氨酸重复区免疫球蛋白样蛋白l(LRIGl)诱导人脑胶质瘤细胞株U251细胞凋亡中的作用及机制。方法传代培养U251细胞,随机分为对照组、空载体组及实验组,应用脂质体介导的基因转染技术分别将磷酸盐缓冲液(PBS)、PEGFP-N1质粒体、PEGFP-LRIG1质粒体转染入各组细胞,应用细胞计数试剂盒(CCK-8)法检测细胞体外生长活性,膜联蛋白V-异硫氰酸荧光素(Annexin V-FITC)/碘化丙锭(PI)法经流式检测各组细胞凋亡率,逆转录-聚合酶链反应(RT-PCR)法测定各组细胞中STAT3的mRNA表达,Westernblot法测定各组细胞中STAT3、磷酸化STAT3(p-STAT3)、B淋巴细胞/白血病-2( bcl-2)、bax的蛋白表达。结果成功转染LRIG1,实验组细胞中LRIG1基因表达明显上调(P〈0.05);实验组细胞增殖显著受抑,48 h抑制率为(45. 12 ±0. 68)%,72h抑制率为(52. 24 ± 1. 77)%,总凋亡率由(2. 54 土0. 43)%增高至(22. 51 ±2. 12)%(P〈0. 05) ; RT-PCR检测显示实验组细胞中STAT3 mRNA表达明显降低;Western blot检测显示实验组细胞中STAT3蛋白表达及磷酸化水平明显降低,bcl-2表达明显降低,bax表达明显升高。结论LRIG1可促进U251细胞凋亡,其机制可能是通过下调STAT3信号通路,进而抑制STAT3激活的抗凋亡途径。 Objective To investigate the effects of signal transducers and activators of transcrip-tion 3 ( STAT3) signaling pathway on leucine-rich repeats and immunoglobulin-like domains 1 ( LRIG1 )-induced apoptosis of U251 cells and the mechansim. Methods U251 cells were cultured and randomly di-vided into three groups: control group, N1-U251 and LRIG1-U251, which were respectively transfectedwith PBS, PEGFP-N1 plasmid and PEGFP-LRIG1 plasmid by liposome transfection. Cell counting kit-8(CCK-8) assay was used to assess the proliferation of U251 cells, and the apoptosis rate by flow cytometryAnnexin V-FITC/PI. The mRNA expression of STAT3 was detected by using reverse transcription-polymerasechain reaction ( RT-PCR) , and the protein expression of STAT3, p-STAT3, B lymphocytes/leukemia-2(bcl-2) and bax by using Western blotting. Results LRIG1 gene was transfected into U251 cells, and theprotein expression level of LRIG1 was significantly upregulated ( P 〈 0. 05). After transfection withLRIG1,proliferation of U251 cells was obviously inhibited with the inhibition rate at 48 and 72 h being(45. 12 ±0. 68)% and (52. 24 ± 1. 77)% respectively, and the total apoptosis rate was increased from(2. 54 ± 0. 43 ) % to ( 22. 51 ± 2. 12 ) % ( P 〈 0. 05 ) ; The mRNA expression level of STAT3 was signifi-cantly downregulated. The protein expression level of STAT3,phosphorylated STAT3 and Bcl-2 was signifi-cantly downregulated, and the protein expression level of Bax was significantly upregulated. ConclusionLRIG1 can downregulate the STAT3 signaling pathway,resulting in block of the antiapoptotic way,to pro-mote apoptosis of U251 cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第4期722-724,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30973072) 国家大学生创新实验项目(111048672)
关键词 胶质瘤 多亮氨酸重复区免疫球蛋白样蛋白1 信号转导和转录激活因子3 脱噬作用 Glioma Leucine-rich repeats and immunoglobulin-like domains 1 Signal trans-ducers and activators of transcription 3 Apoptosis
  • 相关文献

参考文献6

二级参考文献28

  • 1叶飞,郭东升,牛洪泉,陶胜中,欧一博,卢运萍,雷霆.LRIG1cDNA诱导人胶质瘤细胞系H4凋亡的分子机制[J].癌症,2004,23(10):1149-1154. 被引量:19
  • 2叶飞,郭东升,易伟,牛洪泉,舒凯,万锋,卢运萍,雷霆.过度表达LRIG1基因逆转人胶质瘤侵袭性的机制[J].中华实验外科杂志,2005,22(2):200-202. 被引量:26
  • 3沈剑峰,曹浩强,周永庆,詹仁雅,黄琼,徐庆生,马廉亭.脑胶质瘤中环氧化酶-2和血管内皮生长因子的表达及作用[J].中华实验外科杂志,2005,22(3):338-340. 被引量:6
  • 4Nilsson J,Vallbo C,Guo D,et al.Cloning,characterization,and expression of human LIG1.Biochem Biophys Res Commun,2001,284:1151-1161.
  • 5Hedman H,Nilsson J,Guo D,et al.Is LRIG1 a tumour suppressor gene at chromosome 3p14.3? Acta Oncol,2002,41:352-354.
  • 6Gur G,Rubin C,Katz M,et al.LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.EMBO J,2004,23:3270-3281.
  • 7Thomasson M,Hedman H,Guo D,et al.LRIG1 and epidermal growth factor receptor in renal cell carcinoma:a quantitative RT-PCR and immunohistochemical analysis.Br J Cancer,2003,89:1285-1289.
  • 8Tanemura A,Nagasawa T,Inui S,et al.LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin:immunohistochemical analysis for 38 cases.Dermatol Surg,2005,31:423-430.
  • 9Bardia A,William TC.Apoptosis in glioma cells:review and analysis of techniques used for study with focus on the laser scanning cytometer.Neuro-Oncology,2003,23:129-145.
  • 10Klein FA,Herr HW,Sogani PC,et al.Detection and follow-up of carcinoma of the urinary bladder by flow cytometry.Cancer,1982,50:389-395.

共引文献62

同被引文献64

  • 1何江玲.应用人免疫球蛋白联合氨溴索治疗新生儿医院感染性肺炎的疗效观察[J].当代医药论丛,2014,12(7):159-160. 被引量:7
  • 2张丽,国宏莉,田林,曹书芬,度长海.藤梨根正丁醇提取物对人食管癌细胞生长作用的实验研究[J].郧阳医学院学报,2006,25(5):268-270. 被引量:5
  • 3陈谦学,张化明,杨海,吴立权,王军民,邹志鹏,张华.白细胞介素6、信号传导和转录活化因子3和血管内皮生长因子在人脑胶质瘤中的表达及相关性研究[J].中华实验外科杂志,2006,23(12):1457-1459. 被引量:16
  • 4Musacchio M, Perrimon N, The Drosophila kekkon genes: novel members of both the leucine-rich repeat and immunoglobulin superfamilies expressed in the CNS[J]. Dev Biol, 1996, 178(1): 63 -76.
  • 5Nilsson J, Vallbo C, Guo D, et al. Cloning, characterization, and expression of human LIG1 [J]. Biochem Biophys Res Commun, 2001, 284(5): 1155-1161.
  • 6Gur G, Rubin C, Katz M, et al. LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation [J]. EMBO J, 2004, 23(16): 3270-3281.
  • 7Laederich MB, Funes-Duran M, Yen L, et al. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases [J]. J Biol Chem, 2004, 279 (45): 47050-47056.
  • 8Hedman HK, Nilsson J, GuoD, et al. Is LRIG1 a tumour suppressor gene at chromosome 3p14.3 [J]. Acta Oncologica, 2002, 41 (4): 352-354.
  • 9Powell AE, Wang Y, Li Y, et al. The pan-ErbB negative regulator Lrigl is an intestinal stem cell marker that functions as a tumor suppressor[J]. Cell, 2012, 149(1): 146-158.
  • 10Wong VW, Stange DE, Page ME, et al. Lrigl controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling[J]. Nat Cell Biol, 2012, 14(4): 401-408.

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部